Alliance Pharma Plc Receives “Add” Rating from Numis Securities Ltd (APH)
Alliance Pharma Plc (LON:APH)‘s stock had its “add” rating reiterated by research analysts at Numis Securities Ltd in a report released on Wednesday, American Banking and Market News reports. They currently have a GBX 41 ($0.64) price target on the stock. Numis Securities Ltd’s target price would suggest a potential upside of 11.19% from the company’s current price.
Other equities research analysts have also recently issued reports about the stock. Analysts at Canaccord Genuity reiterated a “hold” rating on shares of Alliance Pharma Plc (LON:APH) in a research note to investors on Wednesday, September 4th. They now have a GBX 34 ($0.53) price target on the stock. Separately, analysts at FinnCap reiterated a “hold” rating on shares of Alliance Pharma Plc (LON:APH) in a research note to investors on Thursday, July 11th. They now have a GBX 38.50 ($0.60) price target on the stock. Finally, analysts at Investec downgraded shares of Alliance Pharma Plc (LON:APH) from an “add” rating to a “hold” rating in a research note to investors on Wednesday, June 19th. They now have a GBX 35.80 ($0.56) price target on the stock, up previously from GBX 35.20 ($0.55).
Six equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. Alliance Pharma Plc currently has an average rating of “Hold” and an average target price of GBX 36.82 ($0.58).
Alliance Pharma Plc (LON:APH) opened at 35.00 on Wednesday. Alliance Pharma Plc has a 1-year low of GBX 25.00 and a 1-year high of GBX 40.50. The stock has a 50-day moving average of GBX 33.60 and a 200-day moving average of GBX 35.14.
Alliance Pharma plc is engaged in the acquisition, marketing and distribution of pharmaceutical products.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.